Literature DB >> 7527892

The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients.

D J Evans1, G B Pier, M J Coyne, J B Goldberg.   

Abstract

Strains of Pseudomonas aeruginosa initially isolated from patients with cystic fibrosis (CF) often express a smooth lipopolysaccharide (LPS) containing many long O side-chain antigens, but once a chronic infection is established, strains recovered from these patients express little or no LPS O antigen. The genetic basis for this loss of O antigen expression by P. aeruginosa CF isolates is unknown. We report here that 20 CF isolates of P. aeruginosa, 13 of which are LPS-rough, were each capable of expressing serogroup O11 antigen when provided with the rfb locus from P. aeruginosa serogroup O11 strain PA103 on the recombinant plasmid pLPS2. Eight of the thirteen LPS-rough isolates co-expressed another, presumably endogenous, O antigen when they contained pLPS2. Different subcloned regions of pLPS2 complemented distinct strains to restore endogenous O antigen expression. These data suggest that the loss of O antigen expression by P. aeruginosa CF isolates results from alterations specific to the rfb region, and is not due to mutations involving other loci or ancillary LPS genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527892     DOI: 10.1111/j.1365-2958.1994.tb00437.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  15 in total

1.  Cloning of the glutamyl-tRNA synthetase (gltX) gene from Pseudomonas aeruginosa.

Authors:  C V Franklund; J B Goldberg
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its Metabolism to Promote Biofilm Formation.

Authors:  Sebastián A Riquelme; Kalle Liimatta; Tania Wong Fok Lung; Blanche Fields; Danielle Ahn; David Chen; Carmen Lozano; Yolanda Sáenz; Anne-Catrin Uhlemann; Barbara C Kahl; Clemente J Britto; Emily DiMango; Alice Prince
Journal:  Cell Metab       Date:  2020-05-18       Impact factor: 27.287

4.  Distinct susceptibilities of corneal Pseudomonas aeruginosa clinical isolates to neutrophil extracellular trap-mediated immunity.

Authors:  Qiang Shan; Markryan Dwyer; Samir Rahman; Mihaela Gadjeva
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

5.  Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103.

Authors:  C R Dean; C V Franklund; J D Retief; M J Coyne; K Hatano; D J Evans; G B Pier; J B Goldberg
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

6.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.

Authors:  J C Boucher; H Yu; M H Mudd; V Deretic
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Identification of the mutation responsible for the temperature-sensitive lipopolysaccharide O-antigen defect in the Pseudomonas aeruginosa cystic fibrosis isolate 2192.

Authors:  Michael R Davis; Artur Muszynski; Ivonne V Lollett; Christopher L Pritchett; Russell W Carlson; Joanna B Goldberg
Journal:  J Bacteriol       Date:  2013-01-25       Impact factor: 3.490

Review 9.  Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Authors:  Gerald B Pier
Journal:  Int J Med Microbiol       Date:  2007-04-27       Impact factor: 3.473

10.  Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

Authors:  G B Pier; M Grout; T S Zaidi; J C Olsen; L G Johnson; J R Yankaskas; J B Goldberg
Journal:  Science       Date:  1996-01-05       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.